I will monitor my peak flow regularly, especially when symptoms worsen.
🌬 Regular monitoring of peak expiratory flow helps detect airway narrowing early, even before the client feels severe symptoms.
🌬 Using a peak flow meter is a key part of a personal asthma action plan, allowing objective tracking of control status.
🌬 Changes in peak flow values help determine when to step up rescue medication or seek medical attention according to the written plan.
🌬 Monitoring is especially important when symptoms worsen, because it guides decisions based on established green-yellow-red zones.
🌬 This statement shows understanding of self-management and early detection, which are central to good asthma control.
I should contact my health care provider if I have difficulty breathing or bluish lips.
🌬 Difficulty breathing and bluish lips (cyanosis) are signs of significant hypoxia, indicating poor asthma control or severe exacerbation.
🌬 Promptly contacting the health care provider or emergency services in such cases can prevent respiratory failure.
🌬 Recognizing these as danger signs shows good understanding of when asthma is an emergency and requires immediate help.
🌬 Teaching clients to act quickly when serious symptoms occur is a critical part of asthma education and safety.
🌬 This demonstrates awareness that asthma can become life-threatening and must be taken seriously when severe signs appear.
If my asthma is not controlled, I will adjust my daily controller drug schedule as directed.
🌬 Asthma plans often include stepwise instructions on how to adjust controller medications when symptoms or peak flows change.
🌬 The key phrase “as directed” indicates the client will follow a pre-arranged plan from the provider, not adjust arbitrarily.
🌬 This reflects understanding that controller medicines (like inhaled corticosteroids) are adjusted based on ongoing control, not just symptoms on one day.
🌬 Following a written asthma action plan helps maintain consistent control and reduces exacerbations.
🌬 This statement supports collaborative self-management, which is essential in chronic asthma care.
I can stop my inhaled corticosteroid if I feel no symptoms for a week.
🌬 Inhaled corticosteroids are long-term controller medications that reduce chronic airway inflammation, and they should not be stopped abruptly without provider guidance.
🌬 Asthma can remain inflamed and hyperresponsive even when symptoms are absent, so the absence of symptoms for a week does not mean the disease is gone.
🌬 Stopping a controller medication too soon can lead to loss of control and increased risk of future exacerbations.
🌬 Any change in controller therapy should be based on provider evaluation and the action plan, not on short-term symptom relief alone.
🌬 This statement shows misunderstanding of the maintenance role of corticosteroids in asthma management.
I my rescue inhaler daily even if I have no symptoms.
🌬 A rescue inhaler (short-acting beta-agonist) is meant for acute symptom relief, not for scheduled daily use when asymptomatic.
🌬 Using it daily without symptoms may suggest overuse and can mask poor asthma control, delaying appropriate adjustment of controller therapy.
🌬 Rescue medication should be used only as needed, with frequent use signalling the need to reassess controller options.
🌬 Daily use without symptoms increases exposure to side effects without clinical benefit.
🌬 This statement demonstrates confusion between controller and reliever medications, which is important to correct in teaching.